NCT02048917 - Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies | Biotech Hunter

Enrollment

93

Participants

Timeline

Start Date

July 22, 2014

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions

Lung CancerHead and Neck Cancer

Interventions

DRUG

High Intensity Counseling + Long Acting NRT + PRN NRT

DRUG

High Intensity Counseling + bupropion + PRN NRT

DRUG

High Intensity Counseling + varenicline + PRN NRT

DRUG

High Intensity Counseling + Long Acting NRT

DRUG

High Intensity Counseling + bupropion

DRUG

High Intensity Counseling + varenicline

DRUG

Low Intensity Counseling + Long Acting NRT + PRN NRT

DRUG

Low Intensity Counseling + bupropion + PRN NRT

DRUG

Low Intensity Counseling + varenicline + PRN NRT

DRUG

Low Intensity Counseling + Long Acting NRT

DRUG

Low Intensity Counseling + bupropion

DRUG

Low Intensity Counseling + varenicline

Trial Locations (10)

25702

St. Mary's Medical Center, Huntington

40202

University of Louisville, James Graham Brown Cancer Center, Louisville

40351

St. Claire Regional Medical Center, Morehead

40502

Lexington Veterans Affair Medical Center, Lexington

40536

University Of Kentucky, Markey Cancer Center, Lexington

41101

King's Daughters Medical Center, Ashland

41701

ARH Cancer Center, Hazard

Kentucky Cancer Clinic, Hazard

42303

Owensboro Health, Owensboro

42701

Hardin Memorial Health Cancer Care Center, Elizabethtown